5-40949895-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000587.4(C7):c.983-9C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.64 in 1,501,092 control chromosomes in the GnomAD database, including 309,137 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.66 ( 33663 hom., cov: 31)
Exomes 𝑓: 0.64 ( 275474 hom. )
Consequence
C7
NM_000587.4 intron
NM_000587.4 intron
Scores
2
Splicing: ADA: 0.00001686
2
Clinical Significance
Conservation
PhyloP100: -0.512
Publications
11 publications found
Genes affected
C7 (HGNC:1346): (complement C7) This gene encodes a serum glycoprotein that forms a membrane attack complex together with complement components C5b, C6, C8, and C9 as part of the terminal complement pathway of the innate immune system. The protein encoded by this gene contains a cholesterol-dependent cytolysin/membrane attack complex/perforin-like (CDC/MACPF) domain and belongs to a large family of structurally related molecules that form pores involved in host immunity and bacterial pathogenesis. This protein initiates membrane attack complex formation by binding the C5b-C6 subcomplex and inserts into the phospholipid bilayer, serving as a membrane anchor. Mutations in this gene are associated with a rare disorder called C7 deficiency. [provided by RefSeq, Nov 2016]
C7 Gene-Disease associations (from GenCC):
- complement component 7 deficiencyInheritance: AR Classification: STRONG Submitted by: Ambry Genetics, Illumina, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 5-40949895-C-T is Benign according to our data. Variant chr5-40949895-C-T is described in ClinVar as Benign. ClinVar VariationId is 1170113.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.725 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| C7 | NM_000587.4 | c.983-9C>T | intron_variant | Intron 8 of 17 | ENST00000313164.10 | NP_000578.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| C7 | ENST00000313164.10 | c.983-9C>T | intron_variant | Intron 8 of 17 | 1 | NM_000587.4 | ENSP00000322061.9 |
Frequencies
GnomAD3 genomes AF: 0.665 AC: 100905AN: 151838Hom.: 33640 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
100905
AN:
151838
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.644 AC: 121860AN: 189342 AF XY: 0.642 show subpopulations
GnomAD2 exomes
AF:
AC:
121860
AN:
189342
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.638 AC: 860346AN: 1349136Hom.: 275474 Cov.: 21 AF XY: 0.636 AC XY: 427226AN XY: 671244 show subpopulations
GnomAD4 exome
AF:
AC:
860346
AN:
1349136
Hom.:
Cov.:
21
AF XY:
AC XY:
427226
AN XY:
671244
show subpopulations
African (AFR)
AF:
AC:
23134
AN:
31436
American (AMR)
AF:
AC:
23202
AN:
38036
Ashkenazi Jewish (ASJ)
AF:
AC:
16581
AN:
24870
East Asian (EAS)
AF:
AC:
24815
AN:
37896
South Asian (SAS)
AF:
AC:
48137
AN:
79264
European-Finnish (FIN)
AF:
AC:
34641
AN:
51114
Middle Eastern (MID)
AF:
AC:
3673
AN:
5470
European-Non Finnish (NFE)
AF:
AC:
649735
AN:
1024630
Other (OTH)
AF:
AC:
36428
AN:
56420
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
14447
28894
43342
57789
72236
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
17072
34144
51216
68288
85360
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.665 AC: 100977AN: 151956Hom.: 33663 Cov.: 31 AF XY: 0.665 AC XY: 49398AN XY: 74246 show subpopulations
GnomAD4 genome
AF:
AC:
100977
AN:
151956
Hom.:
Cov.:
31
AF XY:
AC XY:
49398
AN XY:
74246
show subpopulations
African (AFR)
AF:
AC:
30360
AN:
41458
American (AMR)
AF:
AC:
9544
AN:
15232
Ashkenazi Jewish (ASJ)
AF:
AC:
2328
AN:
3466
East Asian (EAS)
AF:
AC:
3517
AN:
5158
South Asian (SAS)
AF:
AC:
2921
AN:
4818
European-Finnish (FIN)
AF:
AC:
7276
AN:
10566
Middle Eastern (MID)
AF:
AC:
211
AN:
294
European-Non Finnish (NFE)
AF:
AC:
42951
AN:
67942
Other (OTH)
AF:
AC:
1385
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1745
3490
5236
6981
8726
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
804
1608
2412
3216
4020
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2244
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:2
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
dbscSNV1_RF
Benign
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.